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The long-lasting modulating effect induced by the prenatal
or neonatal exposure to phenobarbital (PB) and aroclor on
the genotoxk activity of 7,12-dimethylbenz[a]anthracene
(DMBA) in female Sprague-Dawley rats was studied. The
effect was measured as DNA damage evaluated in the liver
and in the mammary gland of 55-day-old animals, 4 and 24 h
after an i.g. injection of 80 mg/kg of DMBA. PB was given
per os, i.g. or in drinking water to pregnant females and by
i.g. only to neonates or in adult progeny. Aroclor was injected
i.g. in prenatal and in neonatal life, and a second dose was
given in adult life. Under these experimental conditions it was
shown that DNA damage kinetics caused by DMBA are
modulated by exposure to PB and, to a minor extent, by
aroclor. The amount and persistence of DNA damage were
highest when PB was administered to neonates. An average
2-fold increase in the elution constants (A) of DNA in the liver
and the mammary gland was observed 4 h after DMBA treat-
ment, as compared to uninduced animals. Repeated enzyme
induction by PB seems to reduce DMBA genotoxkity, as
shown by a decrease in DNA damage and persistence in the
liver and mammary gland. The inducibih'ty of the mono-
oxygenase enzyme system in perinatal life favouring metabolic
activation or inactivation of polycyclic aromatic hydrocarbons
might be critical in determining individual susceptibility of
adult progeny to chemical carcinogenesis by DMBA.
Introduction
Polycyclic aromatic hydrocarbons (PAH) are an ubiquitous class
of environmental chemicals, many of which are known to be
carcinogenic in animal models. The ability of PAH, such as
7,12-dimethylbenz[a]anthracene (DMBA), to induce mammary
tumours in female rats is well documented (Huggins and
Fukunishi, 1962; Dao, 1964; Russo et al., 1977; Huggins, 1979)
Reports have shown that the induction of these neoplasms is
related to the age of the animals at the time of carcinogen feeding
(Huggins etal., 1961; Dao etal., 1964; Dao, 1969). In fact,
one of the most important factors determining the sensitivity of
the mammary gland to neoplastic stimuli is its stage of maturation
at the time of exposure to the carcinogenic agent. With DMBA
the maximum effect was observed in 55-day-old Sprague-Dawley
females where up to 100% incidence of mammary tumours was
observed (Dao, 1969). A direct relationship was demonstrated
between the age at treatment, the binding of DMBA to DNA
and the incidence of mammary tumours (Janss and Ben, 1978).
Many factors can potentially modulate the susceptibility of
laboratory animals to tumour induction by PAH. Most relevant
is the cytochrome-P450-dependent metabolism, a process known
to activate PAH to metabolic derivatives exerting biological
effects, such as cytotoxicity, DNA damage, mutagenesis and
carcinogenesis (Di Giovanni and Jachen, 1980). The oxidative
enzymes of the endoplasmic reticulum which metabolize PAH
are low or barely detectable in rodents at earlier fetal stages and
increase during the perinatal period of life (Gillette and Stripp,
1975; Doerjer etal., 1978; Pelkonen, 1980). In some rodent
strains these enzyme activities may be increased by the
transplacental exposure to enzyme inducers (Nebert and Gelboin,
1969; Nebert, 1973; Jefcoate, 1983). As a consequence, enhanced
tumour initiation by PAH might occur in the offspring.
Our investigation was designed to evaluate DMBA-induced
DNA damage in the mammary gland and in the liver of
Sprague-Dawley female rats treated with PAH inducers during
prenatal and neonatal life. The detection of an increased level
of DNA damage in target tissues suggests that perinatal
modulation of P450-dependent metabolism can have lasting
effects in adult life.
Materials and methods
Chemicals
DMBA, phenobarbital (PB) and arodor 1254 were obtained from Sigma Biochem
(St Louis, MO, USA). 33258 Hoechst a-(2-{4-hydnwyphenyl)-6-benzimi-
dazole]-6-(l-methyl-4-piperazyl)-benzimidazole trihydrochloride) was from
Farbwerkc Hoechst (FRO). DMBA was suspended in corn oil. PB was dissolved
in corn oil or tap water and aroclor was suspended in corn oil.
Treatment and handling of the animals
Pregnant Sprague—Dawley rats were purchased from Charles River (Como, Italy)
and housed in a temperature-controlled room (22-23°C) under artificial lighting
(12 h light). Standard pelleted diet (Italiana Mangimi, Milano, Italy) and drinking
water were supplied ad libitum. The animals were divided in nine groups according
to the scheme outlined in Table I. At the time of DMBA treatment there were
12 females per group: eight of them were given DMBA and four were left
untreated. The compounds were given per os. In pregnant females treatment with
PB was done i.g. (60 mg/kg body wt) or in drinking water (0.5 mg/kg body
wt) from days 14 to 20 of gestation, while aroclor was administered i.g. at a
dose of 100 mg/kg body wt on days 14, 16, 18 and 20 of pregnancy. Newborn
were treated per i.g. from day 1 to 7 of age in two ways: daily with PB (60 mg/kg
body wt) and one every other day with aroclor (100 mg/kg body wt). At 55 days
of age females were treated i.g. with a single dose of DMBA 80 mg/kg b.w.
At 24 and 72 h before DMBA treatment the animals of groups 3 and 5 were
given a single i.g. dose of phenobarbital (60 mg/kg body wt), while those of
groups 6, 7 and 8 received arcclor (500 mg/kg body wt).
Preparation of crude nuclei
Rats belonging to each group were sacrificed as follows: those which received
DMBA were decapitated under slight narcosis and bled 4 and 24 h after treat-
ment with carcinogen, the remaining untreated animals were sacrificed in the
same way and used as controls. Mammary glands and livers were removed and
processed to obtain crude nuclei. Tissues were handled at 0 - 4 ° C . Briefly, the
liver was minced and pressed through a stainless steel net in order to obtain cells
stripped from adhering tissues. Crude nuclei were centrifuged at 50 g for 2 min.
Pelleted crude nuclei were resuspended in 0.075 M NaCl, 0.024 M Na3EDTA
(saline EDTA), pH 7.4. All the mammary glands were separated from the lymph
nodes, pooled and minced. The minced tissue was then incubated in a solution
of collagenase HI 0.3% in phosphate-buffered saline (PBS; 10 ml/g of tissue).
To yield a cell pellet free of fat cells, the minced tissue was swirled on a gyratory
water bath shaker at 150 r.p.m. at 37°C for - 9 0 min or until the suspension
was uniform without any macroscopic lumps. Tissue suspensions were centrifuged
and washed with PBS. Pellets containing mammary epithelial and stromal cells
were utilized for DNA damage evaluation (Moon et al, 1969; Yang et aL, 1980).
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Table
Group
I. General
number
design of the experiments
Amount
Prenatal1
(mg/kg body wt) of agents administered at the given
Neonatalb
developmental stage
Young adult females0
PB, 60
PB, 0.5 in drinking water
PB, 0.5 in drinking water
Ar, 100
PB, 60
Ar, 100
PB, 60
PB, 60
Ar, 500
Ar, 500
Ar, 500
DMBA, 80
DMBA, 80
DMBA, 80
DMBA, 80
DMBA, 80
DMBA, 80
DMBA, 80
DMBA, 80
DMBA, 80
Treatments were performed by i.g., except as indicated.
T h e agents were given from day 14 to 20 of gestation. Treatment with PB was performed once a day. Aroclor (Ar) was given on days 14, 16, 18 and 20.
"TB was administered once a day on days 1 to 7 of age. Aroclor was given on days 1, 3, 5 and 7 of age.
TJMBA was given to 55-day-old Sprague -Dawley females. PB and aroclor were administered 24 and 72 h before DMBA exposure, respectively.
Table U. Modulating effects of PB on DNA damage induced in the liver and the mammary gland by DMBA given to 55-day-old Sprague-Dawley female rats
' (ml"1) X 103 of group no.b
Time after DMBA
treatment (h)
Liver
Controls0
4
24
Mammary gland
Controls0
4
24
31
39
37
23
43
42
±
±
±
±
±
±
5
2
4»
1
5
4
25
76
40
33
81
41
±
±
±
±
±
±
2
7
3
4
10
3
32
46
45
29
57
52
±
±
±
±
±
±
3
3
10
5
9
10
26
50
47
28
69
46
±
±
±
±
±
4
10
10
2
12
10
36
46
25
35
45
30
±
±
±
±
±
±
7
7
3»
1
1
6*
27
45
36
30
48
31
±
±
±
±
±
4
7
4*
3
3
3»
•Mean ± S.D. of a minimum of four experiments (8 — 12 determinations).
"Treatments of each experimental group are detailed in Table I.
These animals were exposed to the enzyme inducers but did not receive DMBA.
The values were significant at P < 0.005 by the Mann-Whitney test. *Not significant.
Alkaline elusion of DNA
DNA damage, as single-strand breaks or weak points in alkali, was measured
by the alkaline elution technique (Bolognesi et al., 1985). Briefly, aliquots
containing 0.5 — 1.0 x 106 nuclei were applied to membrane filters (Millipore
Corp., USA; 25 mm diameter, 5 fim pore size). Crude nuclei on the filters were
lysed at room temperature. Single-stranded DNA fractions were eluted with a
solution containing 0.04 M EDTA, tetra ethylammonium hydroxide (TEA 10%
in water) to provide a pH of 12.3. Fractions were collected al 6 min intervals
for 1 h and the flow rate was 0.34 ml/min. Fluorimetric determination of DNA
was performed with 33258 Hoechst reagent according to the method developed
in our laboratory (Cesarone et aL, 1979). The results were expressed as elution
rate constant (K):
Af (ml"1) = - I n fraction of DNA retained on the filter
eluted volume
The standard deviation and the non-parametric Mann—Whitney tests were used
for the statistical analysis (Siegle, 1956).
Results
The mammary gland is a known target tissue for DMBA initiated
carcinogenesis, while the liver is the most susceptible organ to
DNA damaging agents and a major site of drug metabolism.
Following a preliminary approach indicating that no DNA strand
breaks are revealed when these organs were taken 2 h after
treatment (values of K were in the range of the untreated animals),
we chose 4 h as the minimum interval sufficient to allow detection
of a significant amount of DNA damage and 24 h as a period
interval sufficient to measure persistence of the damage. The
results are summarized in Tables II and HI. A significant amount
of DNA damage in the liver and the mammary gland of control
females was observed 4 h after DMBA treatment with a value
of K of 45 and 48, respectively. At 24 h the damage disappeared
and was similar to that found in the untreated animals.
Enzyme induction by PB in different developmental stages
Pretreatment with PB generally caused an increase in DNA
damage induced by DMBA in the liver and mammary gland
compared to controls, both in terms of a raised elution rate and
of its persistence in time. The extent and the time course of this
enhanced effect was particularly significant when PB treatment
was performed during neonatal life (group 2 in Table II and
Figure 1A and B). In this instance the average elution constant,
evaluated 4 h after DMBA treatment, was ~ 2-fold higher with
respect to the values obtained in the same organs of the uninduced
animals (in the liver it was 76 versus 45 and in the mammary
gland it was 81 versus 48, respectively).
When two different treatment modalities were adopted to
expose prenatal animals to PB induction, it was shown that
administration in drinking water was more effective compared
to exposure by i.g. This was indicated by a statistically significant
increase in DNA damage observed in the liver and mammary
gland of the animals given the former treatment schedule and
evaluated 4 h after treatment with DMBA (groups 1 and 4 in
Table U).
114
DNA damage induced by DMBA
Table m . Modulating effects
liver and the mammary gland
Sprague-Dawley female rats
Time after DMBA
treatment (h)
Liver
Controls0
4
24
Mammary gland
Controls'
4
24
K° (ml
6
30 ±
50 ±
45 ±
30 ±
52 ±
45 ±
of aroclor
by
3
3
6
10
10
7
DMBA
x 103
7
28
39
34
32
46
37
on DNA
given to
of group
±
±
±
±
±
±
5
4
6*
10
8
3
damage induced
55-day-old
no.b
8
27 ±
45 ±
38 ±
30 ±
45 ±
34 ±
7
7
4
3
8
6*
in the
9
27
45
36
30
48
31
±
±
±
±
±
±
7
7
4*
3
3
3*
'Mean ± S.D. of a minimum of four experiments (8-12 determinations).
"Treatments of each experimental group are detailed in Table I.
These animals were exposed to the enzyme inducers but did not receive
DMBA.
The values were significant at P < 0.005 by the Mann-Whitney test. *Not
significant.
Following this result repeated enzyme induction was performed
by giving PB in drinking water during pregnancy and by i.g.
in 54-day-old female progeny. This schedule caused a decrease
in the extent and persistence °f DNA damage by DMBA, as
shown by the comparison of groups 4 and 5 in Table II.
Effects of enzyme induction by aroclor
Aroclor was given to pregnant rats or newborn and a second
exposure was given to 52-day-old females (groups 6 and 7,
respectively). Other females were left intact and given aroclor
at 52 days of age (group 8). These groups were then treated with
DMBA on day 55. Under these experimental conditions there
was no significant increase in DNA damage in the liver and
mammary gland evaluated in the several treated and control
groups. However, 24 h after DMBA treatment an increase in
die persistence of DNA damage was observed in the liver and
mammary gland of the animals of group 6 compared to those
of group 9 (K in the liver was 45 versus 36 and 45 versus 31
respectively).
Discussion
Drug metabolizing activities appear late in pregnancy or
immediately after birth and progressively increase during the first
weeks of life (Gillette and Stripp, 1975; Doerjer et al., 1978;
Pelkonen, 1980). Several factors have been suggested or
recognized to influence the ontogenesis of these enzymatic
activities (Pelkonen, 1980; Klinger, 1982). The complexity of
the possible metabolic pathways of DMBA provides many
opportunities for alteration of the balance between production
of highly carcinogenic and mutagenic derivatives and of inert
detoxified products.
Our results indicate that DNA damage kinetics caused by
DMBA are modulated by previous treatment with PAH inducers,
such as PB and aroclor, during prenatal and neonatal life. A
pronounced increase in DNA damage was demonstrated after PB
induction, while only a marginal increase was evident following
treatment with aroclor. In both cases it may be hypothesized that
a different ratio of cytochromes P448/P450 is induced, resulting
in impaired or improved detoxification of DMBA.
There exists a peculiar immaturity of inactivating versus
activating enzymes in perinatal life (Rice, 1979), a phenomenon
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Fig. 1. Time-dependence of the elution constant in alkali of DNA from liver
(panel A) and mammary gland (panel B) of young-adult Sprague-Dawley
female rats treated with DMBA (80 mg/kg, i.g.). The animals were induced
with PB 60 mg/kg i.g. in prenatal ( • - • ) , neonatal ( • • ) and adult life
( • • ) or uninduced ( A - A ) .
diat might explain our observation of the increased DNA damage
by DMBA in young adult females exposed to PB in utero or
during neonatal life. It appears that die induction of die enzyme
system responsible for the metabolic activation of DMBA is more
effective when it is performed in neonates compared to fetal and
adult organisms, shown by die observation diat DNA damage
was increased by neonatal treatment widi PB. These confirm
previous reports diat the neonatal period of development is critical
to the maturation of microsomal enzymes (Pelkonen, 1980;
MacDonald et al., 1981; Assael, 1982). Although it is believed
diat during pregnancy enzyme inducers are barely effective in
inducing the microsomal enzyme system (Romano et al., 1983),
at least one report has suggested an inductive effect in increasing
metabolic activation of benzo[a]pyrene during organogenesis
(Bolognesi etal., 1985).
DMBA is considered a potent initiator of mammary
tumorigenesis in rats. It is currentiy accepted diat die binding
of chemical carcinogens to DNA is an important early step in
the carcinogenic process (Harvey, 1985). DNA binding and DNA
adducts by DMBA metabolites have been studied in numerous
cell systems in vitro (Sawicki et al., 1983; Singletary and Milner,
1986) and in vivo (Di Giovanni and Jachen, 1980; Cheng et al.,
1988; Moore et al., 1988), where it was shown diat the liver
and the mammary gland are die primary target. The metabolism
of DMBA to electrophilic ultimate carcinogens is assumed to be
a prerequisite for initiation of its carcinogenic effects. The
metabolic fate of a compound is a function of diree processes
occurring togedier (activation, deactivation and reactivation)
whose dynamic interaction results in die local concentration and
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lifetime of the active metabolites. In this context it is interesting
that repeated stimulation of the microsomal enzyme system by
PB has resulted in a shorter persistence of DNA damage
compared to controls. One could guess that the repeated
enzymatic stimulation changes the metabolic pathway of DMBA
in such a way that DNA adducts are efficiently repaired.
Modulation of the metabolic performance of xenobiotics has
a great toxicologic relevance in terms of differential susceptibility
to chemical carcinogens. Many environmental pollutants and
drugs appear to be modifiers of enzymatic activities. Therefore
the exposure of developing organisms to these agents during pre-
and neonatal life could affect the individual susceptibility of adult
progeny to different classes of chemical carcinogens.
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